1. Home
  2. Labeler Index
  3. Shilpa Medicare Limited
  4. 63759-3032
  5. NDC Package Code: 63759-3032-1 Bortezomib

NDC Package 63759-3032-1 Bortezomib

Injection Intravenous; Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
63759-3032-1
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 1.4 mL in 1 VIAL, SINGLE-DOSE
Product Code:
63759-3032
Proprietary Name:
Bortezomib
Non-Proprietary Name:
Bortezomib
Substance Name:
Bortezomib
Usage Information:
This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer cells.
11-Digit NDC Billing Format:
63759303201
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Shilpa Medicare Limited
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s):
BORTEZOMIB 3.5 mg/1.4mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
NDA212782
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
09-25-2024
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 63759-3032-1?

The NDC Packaged Code 63759-3032-1 is assigned to a package of 1 vial, single-dose in 1 carton / 1.4 ml in 1 vial, single-dose of Bortezomib, a human prescription drug labeled by Shilpa Medicare Limited. The product's dosage form is injection and is administered via intravenous; subcutaneous form.

Is NDC 63759-3032 included in the NDC Directory?

Yes, Bortezomib with product code 63759-3032 is active and included in the NDC Directory. The product was first marketed by Shilpa Medicare Limited on September 25, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 63759-3032-1?

The 11-digit format is 63759303201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-163759-3032-15-4-263759-3032-01